The European Journal of Preventive Cardiology, published by Oxford University Press, is a leading international journal dedicated to the field of cardiology and cardiovascular medicine. With an impact factor that underscores its prestige—ranking in the top quartile (Q1) of both cardiology and epidemiology categories—the journal serves as a critical resource for researchers and practitioners seeking to advance their understanding of preventive strategies in cardiovascular health. Since its inception in 1999, it has provided a platform for high-quality research and reviews that address the epidemiology of cardiovascular diseases, risk factor management, and innovative prevention methodologies. Notably, it currently ranks #21 out of 387 in Medicine - Cardiology and #13 out of 148 in Medicine - Epidemiology according to Scopus, highlighting its influential position in these essential biomedical fields. The journal also provides open access options, allowing both readers and authors the opportunity to engage with groundbreaking research and enhance the dissemination of knowledge. With a commitment to excellence, the European Journal of Preventive Cardiology is an invaluable asset for those dedicated to the prevention of cardiovascular diseases.

Welcome to the Journal of Cardiovascular Medicine, a leading platform for the dissemination of high-quality research in the field of cardiology and cardiovascular medicine. Published by Lippincott Williams & Wilkins, this esteemed journal boasts an ISSN of 1558-2027 and an E-ISSN of 1558-2035, reflecting its commitment to accessible and innovative cardiovascular research. With a significant impact factor and ranked Q2 in both Cardiology and Cardiovascular Medicine as well as in Medicine (Miscellaneous) for 2023, the journal is recognized for its contributions to advancing knowledge and practice in this critical area of health. The journal disseminates original research, reviews, and clinical studies, aimed at clinicians, researchers, and healthcare professionals who are dedicated to improving cardiovascular health outcomes. With a continuous commitment to evolving research from 2006 to 2024, the journal is an essential resource for those looking to stay at the forefront of the latest discoveries and methodologies in cardiovascular medicine.

Cardiovascular Revascularization Medicine, published by Elsevier Inc, serves as a pivotal platform for research and clinical advancements in the field of cardiology and cardiovascular medicine. With an ISSN of 1553-8389 and an E-ISSN of 1878-0938, this journal has been a key resource since its inception in 2005, converging to highlight innovative approaches for cardiovascular interventions and revascularization techniques through 2024. Although it currently holds a Q3 ranking in both cardiology and general medicine categories as per the 2023 metrics, it continues to empower researchers and healthcare professionals by publishing peer-reviewed articles that bridge the gap between experimental and clinical medicine. With comprehensive coverage of emergent therapies and procedural advancements, Cardiovascular Revascularization Medicine is essential for anyone aiming to stay abreast of the evolving landscape of cardiovascular treatment. Researchers, professionals, and students alike will find invaluable insights and evidence-based research that can impact patient outcomes positively.

The Anatolian Journal of Cardiology, published by KARE PUBL, stands as a vital resource in the field of Cardiology and Cardiovascular Medicine. With an ISSN of 2149-2263 and E-ISSN 2149-2271, this Open Access journal has been fostering the dissemination of critical research since 2001, ensuring that high-quality content is freely available to a global audience. Based in Turkey, the journal aims to bridge gaps in cardiological knowledge through rigorous peer-reviewed articles that span a wide range of topics, from innovative clinical practices to groundbreaking research findings. While its current ranking places it in the Q3 category of cardiology journals, the Anatolian Journal of Cardiology continues to strive towards enhancing its impact, currently holding a Scopus rank of 236 out of 387. Researchers, practitioners, and students alike will find this journal an essential platform for keeping abreast of the latest developments in cardiovascular health.

Indian Heart Journal, published by Elsevier, is a distinguished peer-reviewed journal dedicated to the field of cardiology and cardiovascular medicine. Founded in 1961, this journal has been a pivotal resource for researchers, healthcare professionals, and students, providing a platform for innovative studies and insights into heart health. The journal transitioned to an Open Access model in 2013, ensuring widespread dissemination of vital research findings to enhance global understanding of cardiovascular diseases. Ranked in the Q3 category for Cardiology and Cardiovascular Medicine in 2023, it holds a reputable position in the medical community, with a Scopus rank of #222 out of 387 journals in the same field, placing it in the 42nd percentile. The Indian Heart Journal strives to foster advances in clinical practice and research while addressing the unique cardiac health challenges faced in India and beyond.

Canadian Journal of Cardiology (ISSN: 0828-282X, E-ISSN: 1916-7075), published by Elsevier Science Inc, serves as a vital platform for disseminating high-quality research in the dynamic field of cardiology and cardiovascular medicine. Since its inception in 1985, this journal has established itself as a leader in the field, currently holding a prestigious Q1 ranking in Cardiology, indicating its significant impact and contribution to medical science. With a Scopus rank of #50 out of 387 in its category and placing in the 87th percentile, the journal showcases rigorous peer-reviewed articles that advance knowledge and practice in cardiology. Although the journal is not open access, it provides valuable insights and research findings that cater to clinicians, researchers, and students who are committed to improving cardiovascular health. As we approach the convergence of years to 2024, the Canadian Journal of Cardiology continues to strive for excellence, facilitating a discourse vital for both academic and clinical advancements in cardiology.

Nepalese Heart Journal, published by the CARDIAC SOC NEPAL, serves as a premier platform for disseminating knowledge in the field of cardiology and cardiovascular health. With an ISSN of 2091-2978, this journal aims to bridge the gap between researchers, clinicians, and academicians by presenting high-quality, peer-reviewed articles that address clinical practices, innovative research, and emerging trends in heart disease management, especially within the context of Nepal and the surrounding region. Although it operates under a traditional publishing model, its commitment to excellence aids in reinforcing the scientific discourse in an area critical to public health. The journal is a valuable resource for professionals and students alike who are focused on advancing their understanding of cardiology and its implications for health policy and practice. Exploring the intersections of local challenges and global advancements in heart health, the Nepalese Heart Journal is poised to contribute meaningfully to the evolving landscape of cardiovascular research.

The Journal fur Kardiologie, published by KRAUSE & PACHERNEGG GMBH, is a pivotal resource in the field of Cardiology and Cardiovascular Medicine. With an ISSN of 1024-0098 and an E-ISSN of 1680-936X, this journal has played a significant role in disseminating valuable research and clinical studies from 1998 until its coverage discontinuation in Scopus in 2017. Despite its Scopus rank being relatively low at #316/324 in its category, it continues to serve as a platform for emerging cardiology research. The journal’s scope encompasses various aspects of cardiovascular health, providing insights that are crucial for researchers, professionals, and students alike seeking to advance their knowledge and practice in cardiology. While the journal is not open access, its contributions to the field are essential for those looking to stay informed about the latest developments in cardiovascular medicine.

Journal of Cardiovascular Development and Disease, an esteemed publication by MDPI, has been a dedicated platform for disseminating cutting-edge research since its inception in 2014. Based in Switzerland, this Open Access journal not only provides unrestricted access to its content but also fosters global collaboration among scholars focusing on cardiovascular health and disease development. With an impressive focus classified as Q1 in Pharmacology, Toxicology and Pharmaceutics for 2023, it attracts a diverse range of interdisciplinary research, supporting advancements in pharmacological applications relevant to cardiac conditions. The journal's ongoing convergence through 2024 highlights its commitment to the evolving landscape of cardiovascular research, making it a vital resource for researchers, professionals, and students alike who are keen to contribute to and learn from significant developments in this critical field.

EuroIntervention is a prestigious academic journal dedicated to the field of cardiology and cardiovascular medicine, published by EUROPA EDITION. Established as an essential resource for researchers and healthcare professionals, the journal holds an impressive Q1 ranking in both Cardiology and Cardiovascular Medicine as of 2023, demonstrating its influence and commitment to advancing knowledge in these fields. With an ISSN of 1774-024X and an E-ISSN of 1969-6213, EuroIntervention aims to publish high-quality research and clinical studies that address contemporary challenges in cardiovascular therapies. The journal is recognized for its rigorous peer-review process, ensuring that each article contributes valuable insights to the community. Researchers will find EuroIntervention a vital platform to disseminate their findings and engage with innovative cardiology techniques. Operating from France, the journal aspires to bridge the gap between research and clinical practice, making it an essential read for cardiologists, medical professionals, and students alike, keen to stay abreast of the latest advancements in cardiovascular care.